Patent ID: 8680109

Claim:
A method for treating breast cancer which comprises administering to a warm-blooded animal that is in need of such treatment effective therapeutic amounts of the components of a pharmaceutical combination of anti-cancer compounds, the pharmaceutical combination comprising as active components: (a) an antioestrogen selected from the group consisting of tamoxifen, non-steroidal aromatase inhibitors anastrazole and letrozole and steroidal aromatase inhibitor exemstane, wherein the tamoxifen is administered at a daily dose of between 5 and 30 mg; the anastrazole and letrozole are administered at a daily dose of between 0.005 and 25 mg; and the exemstane is administered at a daily dose of between 10 and 40 mg; and (b) the Src kinase inhibitor AZD0530, or a pharmaceutically-acceptable salt thereof, wherein the AZD0530 is administered at a daily dose of between 25 mg and 250 mg.